British researchers have developed a new antibiotic using maggots which can be used to treat bugs including some strains of the drug-resistant bacteria MRSA, they announced Tuesday.
A new antibiotic using maggots has been developed by British researchers, which may prove useful in combating drug-resistant bacteria MRSA.
The team from Swansea University in south Wales has created Seraticin, a drug made from the secretions of green bottle fly larvae.
Super-oxidised Water Found Effective Against MRSA
Oculus, a Californian firm has claimed to have developed super-oxidised water, which speeds up healing of a wound.
Oculus, a Californian firm has claimed to have developed super-oxidised water, which speeds up healing of a wound.
Professor Norman Ratcliffe, who led the researchers, said there was more work to be done before the full benefits of the discovery could come to fruition.
"It takes approximately 20 mugs of maggots to yield just one drop of purified Seraticin at present," he said.
Johns Hopkins Begins Aggressive Screening for 'superbugs' in Children
Infection control and critical care experts at The Johns Hopkins Hospital have ordered testing for the two most common hospital superbugs for every child admitted.
Infection control and critical care experts at The Johns Hopkins Hospital have ordered testing for the two most common hospital superbugs for every child admitted.
Source-AFP
RAS/L
Sexually Active Gays Vulnerable To Highly Potent Superbug
Sexually active gay men are at a very high-risk of acquiring a new, highly antibiotic-resistant strain of the MRSA bacteria .
Sexually active gay men are at a very high-risk of acquiring a new, highly antibiotic-resistant strain of the MRSA bacteria .
MRSA can Be Eliminated by Avoiding Intravenous Injections
Winchester and Eastleigh Healthcare NHS Trust has successfully managed to reduce MRSA infection in its hospitals by avoiding administering intravenous injections.
Winchester and Eastleigh Healthcare NHS Trust has successfully managed to reduce MRSA infection in its hospitals by avoiding administering intravenous injections.
